Inger S Nijhof Selected Research

Inger S Nijhof Research Topics

20	Multiple Myeloma 01/2022 - 01/2012
4	Neoplasms (Cancer) 01/2022 - 01/2012
1	Lymphoma (Lymphomas) 01/2022
1	Bronchiolitis Obliterans Syndrome 01/2022
1	COVID-19 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Disease Progression 12/2021
1	Cytokine Release Syndrome 11/2020
1	Bites and Stings (Sting) 11/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2016
1	Exanthema (Rash) 01/2012
1	Thrombocytopenia (Thrombopenia) 01/2012
1	Fatigue 01/2012
1	Neutropenia 01/2012

12	daratumumabIBA 12/2021 - 02/2015
7	Lenalidomide (CC 5013)FDA Link 09/2018 - 01/2012
4	Monoclonal AntibodiesIBA 10/2020 - 06/2015
3	AntibodiesIBA 10/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	ixazomibIBA 01/2021 - 01/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 12/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2018 - 11/2016
2	Prednisone (Sone)FDA LinkGeneric 09/2018 - 11/2016
2	Bortezomib (Velcade)FDA Link 11/2016 - 06/2015
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	ibrutinibIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	ruxolitinibIBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021
1	EpitopesIBA 01/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 11/2020
1	tocilizumab (atlizumab)FDA Link 11/2020
1	SteroidsIBA 11/2020
1	Bispecific AntibodiesIBA 11/2020
1	B-Cell Maturation AntigenIBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 01/2019
1	carfilzomibIBA 01/2018
1	pomalidomideIBA 01/2018
1	elotuzumabIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	PanobinostatIBA 01/2018
1	Complement System Proteins (Complement)IBA 12/2017
1	Thalidomide (Thalomid)FDA Link 01/2012